Journal Article DZNE-2024-00938

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Increased alpha-synuclein and neuroinflammation in the substantia nigra triggered by systemic inflammation are reversed by targeted inhibition of the receptor for advanced glycation end products (RAGE).

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2024
Wiley-Blackwell Oxford

Journal of neurochemistry 168(8), 1587 - 1607 () [10.1111/jnc.15956] special issue: "Aging and Neurodegeneration: from molecular mechanisms to therapeutic interventions"

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: The receptor for advanced glycation end products (RAGE) is a protein of the immunoglobulin superfamily capable of regulating inflammation. Considering the role of this receptor in the initiation and establishment of neuroinflammation, and the limited understanding of the function of RAGE in the maintenance of this condition, this study describes the effects of RAGE inhibition in the brain, through an intranasal treatment with the antagonist FPS-ZM1, in an animal model of chronic neuroinflammation induced by acute intraperitoneal injection of lipopolysaccharide (LPS). Seventy days after LPS administration (2 mg/kg, i.p.), Wistar rats received, intranasally, 1.2 mg of FPS-ZM1 over 14 days. On days 88 and 89, the animals were submitted to the open-field test and were killed on day 90 after the intraperitoneal injection of LPS. Our results indicate that blockade of encephalic RAGE attenuates LPS-induced chronic neuroinflammation in different brain regions. Furthermore, we found that intranasal FPS-ZM1 administration reduced levels of gliosis markers, RAGE ligands, and α-synuclein in the substantia nigra pars compacta. Additionally, the treatment also reversed the increase in S100 calcium-binding protein B (RAGE ligand) in the cerebrospinal fluid and the cognitive-behavioral deficits promoted by LPS-less time spent in the central zone of the open-field arena (more time in the lateral zones), decreased total distance traveled, and increased number of freezing episodes. In summary, our study demonstrates the prominent role of RAGE in the maintenance of a chronic neuroinflammatory state triggered by a single episode of systemic inflammation and also points to possible future RAGE-based therapeutic approaches to treat conditions in which chronic neuroinflammation and increased α-synuclein levels could play a relevant role, such as in Parkinson's disease.

Keyword(s): Animals (MeSH) ; Receptor for Advanced Glycation End Products: antagonists & inhibitors (MeSH) ; Receptor for Advanced Glycation End Products: metabolism (MeSH) ; Rats, Wistar (MeSH) ; Male (MeSH) ; Rats (MeSH) ; alpha-Synuclein: metabolism (MeSH) ; alpha-Synuclein: antagonists & inhibitors (MeSH) ; Substantia Nigra: drug effects (MeSH) ; Substantia Nigra: metabolism (MeSH) ; Neuroinflammatory Diseases: drug therapy (MeSH) ; Neuroinflammatory Diseases: metabolism (MeSH) ; Inflammation: metabolism (MeSH) ; Inflammation: drug therapy (MeSH) ; Lipopolysaccharides: pharmacology (MeSH) ; Lipopolysaccharides: toxicity (MeSH) ; Administration, Intranasal (MeSH) ; Thiazoles: pharmacology (MeSH) ; Benzamides (MeSH) ; gliosis ; neuroinflammation ; receptor for advanced glycation end products ; α‐Synuclein ; Receptor for Advanced Glycation End Products ; alpha-Synuclein ; FPS-ZM1 ; Lipopolysaccharides ; Thiazoles ; Benzamides

Classification:

Contributing Institute(s):
  1. Epigenetics and Systems Medicine in Neurodegenerative Diseases (AG Fischer)
Research Program(s):
  1. 352 - Disease Mechanisms (POF4-352) (POF4-352)

Appears in the scientific report 2024
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > GÖ DZNE > GÖ DZNE-AG Fischer
Public records
Publications Database

 Record created 2024-08-06, last modified 2024-08-11


Fulltext:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)